Table 3 Tumor characteristics of the matched groups
Intra-arterial | No intra-arterial | p value | |
|---|---|---|---|
Patients (n) | 26 | 78 | |
Pathologic stage outcome, n (%) | 0.414 | ||
pT1 | 9(34.6%) | 26(33.3%) | |
pT2a | 6(23.1%) | 11(14.1%) | |
pT2b | 1(3.8%) | 14(17.9%) | |
pT3a | 6(23.1%) | 11(14.1%) | |
pT3b | 3(11.5%) | 3(3.8%) | |
pT4a | 1(3.8%) | 13(16.7%) | |
Histology grade, n (%) | 0.566 | ||
Low grade | 6(23.1%) | 14(17.9%) | |
High grade | 20(76.9%) | 64(82.1%) | |
Pathology, n (%) | 0.399 | ||
Urothelial cancer | 21(80.8%) | 71(91.0%) | |
Urothelial cancer with squamous differentiation | 3(11.5%) | 4(5.1%) | |
Urothelial cancer with glandular differentiation | 2(7.7%) | 3(3.8%) | |
Nodes removed, median (IQR) | 17.0(11.8–21.3) | 14.0(8.0–19.0) | 0.304 |
PLN, median (range) | 0.0(6.0) | 0.0(27.0) | 0.904 |
Lymph-node-positive patients, n (%) | 7(26.9%) | 18(23.1%) | 0.691 |
Positive surgical margins, n (%) | 0(0.0%) | 3(3.8%) | 0.571 |
Associated CIS, no. (%) | 4(15.4%) | 12(15.4%) | 1.000 |